
McDonald's stock rallies 20% amid debate over impact of weight-loss drugs and real estate value.
McDonald's shares have surged over 20% in a month, driven by improved U.S. traffic and value pricing strategies. However, debate persists among investors: one argues that GLP-1 weight-loss drugs could reduce demand for fast food long-term, while anot...





